Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial.

Author:

Kim Dong-Wan1,Mehra Ranee2,Tan Daniel Shao-Weng3,Felip Enriqueta4,Chow Laura Quan Man5,Camidge D. Ross6,Vansteenkiste Johan F.7,Sharma Sunil8,De Pas Tommaso9,Riely Gregory J.10,Solomon Benjamin J.11,Wolf Juergen12,Thomas Michael13,Schuler Martin H.14,Liu Geoffrey15,Santoro Armando16,Geraldes Margarida17,Boral Anthony18,Yovine Alejandro Javier19,Shaw Alice Tsang20

Affiliation:

1. Seoul National University Hospital, Seoul, South Korea

2. Fox Chase Cancer Center, Philadelphia, PA

3. National Cancer Centre, Singapore, Singapore

4. Vall d'Hebron University Hospital, Barcelona, Spain

5. University of Washington, Seattle, WA

6. University of Colorado Cancer Center, Aurora, CO

7. University Hospital KU Leuven, Leuven, Belgium

8. University of Utah Huntsman Cancer Institute, Salt Lake City, UT

9. Instituto Europeo di Oncologia, Milan, Italy

10. Memorial Sloan Kettering Cancer Center, New York City, NY

11. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

12. University Hospital Cologne, Cologne, Germany

13. Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany

14. University Hospital Essen, University Duisburg-Essen, Essen, Germany and German Cancer Consortium, Heidelberg, Germany

15. Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada

16. IRCCS Institute Clinico Humanitas, Milan, Italy

17. Novartis Pharma, East Hanover, NJ

18. Novartis Institutes for BioMedical Research, Cambridge, MA

19. Novartis Pharma AG, Basel, Switzerland

20. Massachusetts General Hospital, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3